CLINICAL_TRIALS
trial_result
· 2012-02-17
Clinical Trial Update: An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression [Phase 3]
Summary
A Phase 3 clinical trial evaluating the efficacy and safety of Saredutant in patients with depressive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Depressive Disorder | Phase 3 | Status: COMPLETED